Clinical Trial Update: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Dry Eye Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a treatment for Dry Eye Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Snippet

Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED